Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

Delayed Quote. Delayed  - 05/31 09:59:55 pm
0.615 USD   +0.82%
05/19 CATALYST PHARMA : Firdapse Phase 3 Study Published in Muscle & Nerve
05/18 Catalyst Pharmaceutical’s Firdapse Phase 3 Study Published ..
05/18 CATALYST PHARMA : Announces Reduction in Workforce as Part of Operat..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/24/2016 05/25/2016 05/26/2016 05/27/2016 05/31/2016 Date
0.62(c) 0.6196(c) 0.6061(c) 0.61(c) 0.615(c) Last
529 325 537 556 260 136 384 355 291 767 Volume
+3.75% -0.06% -2.18% +0.64% +0.82% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -24,0 M
Net income 2016 -23,5 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -25,0 M
Net income 2017 -14,9 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 0
Capitalization 51,0 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.The... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
05/19 CATALYST PHARMACEUTICALS : Firdapse Phase 3 Study Published in Muscle & Nerve
05/18 Catalyst Pharmaceutical’s Firdapse Phase 3 Study Published in Muscle & ..
05/18 CATALYST PHARMACEUTICALS : Announces Reduction in Workforce as Part of Operating..
05/17 Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operatin..
05/10 Catalyst Pharmaceuticals Announces First Quarter 2016 Financial Results and P..
05/06 Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference C..
04/26 TUESDAY SECTOR LAGGARDS : Biotechnology, Drugs
04/26 Catalyst Pharmaceuticals Provides Regulatory Update on Firdapse
03/15 CATALYST PHARMACEUTICALS : reports 4Q loss
03/15 Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial..
More news
Sector news : Bio Therapeutic Drugs
05/31 INCYTE : Announces the Launch of the Incyte Charitable Giving Foundation
05/31 QIAGEN NV : Integrates Quality Control Tools into GeneReader NGS System
05/31 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
05/31 ALNYLAM PHARMACEUTICALS : to Webcast Presentations at Upcoming June Investor Con..
05/31 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/23 EXPLORING GRAHAM'S NET-NET WORKING C : Avoid Investing Like Icarus
05/17 Catalyst cuts workforce 30% to conserve resources
05/11 Catalyst Pharmaceutical Partners' (CPRX) CEO Pat McEnany on Q1 2016 Results -..
05/10 Catalyst Pharmaceutical EPS in-line
04/26 Midday Gainers/ Losers
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions